ArticleClinics (Sao Paulo, Brazil)2026
Correlation and discriminatory performance of non-invasive serum fibrosis indices according to liver disease etiology using two-dimensional shear wave elastography as reference.
Article in Clinics (Sao Paulo, Brazil), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
BACKGROUND/
objectivesNon-invasive serum fibrosis indices are widely used for liver fibrosis assessment; however, their correlation with liver stiffness and diagnostic performance may vary according to liver disease etiology. This study aimed to evaluate the etiology-dependent correlation between multiple serum Non-Invasive Test (NITs) indices and liver stiffness measured by two-dimensional Shear Wave Elastography (2D-SWE), and to explore their ability to discriminate patients according to 2D-SWE-based fibrosis categories.
methodsWe conducted a retrospective cross-sectional study including 105 patients with chronic liver disease. Serum NITs indices were correlated with liver stiffness measured by 2D-SWE using Pearson or Spearman correlation Exploratory ROC curve analyses were performed to assess the ability of serum indices to discriminate 2D-SWE-based fibrosis categories by etiology.
resultsStrong intercorrelations were observed among multiple serum NITs indices across all etiological groups, indicating substantial collinearity. In metabolic-associated steatotic liver disease, alcohol-related liver disease, and metabolic dysfunction-associated alcohol-related liver disease, correlations between serum indices and liver stiffness were weak to moderate. In contrast, viral hepatitis showed moderate and statistically significant correlations between several indices and 2D-SWE, with more consistent diagnostic performance in ROC analyses. Autoimmune hepatitis demonstrated an intermediate pattern, with modest but significant associations between selected indices and liver stiffness. Exploratory ROC analyses showed heterogeneous discriminatory performance across etiologies.
conclusionsSerum NITs indices exhibit high collinearity and etiology-dependent performance. Their correlation with liver stiffness and their discriminatory performance against 2D-SWE-based fibrosis categories vary according to underlying liver disease supporting the complementary rather than interchangeable use of serum indices and elastography.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.